TGFBR3 and liver disorder: We demonstrate here that SULF2 exerts its effect on fibrotic liver disease via its interplay with the TGF-β1/Smad pathway and that the TGFBR3 likely plays an important role in the SULF2 mediated activation of the TGF-β1 signaling pathway.